STUDY OF CLINICAL CORRELATION OF MICROALBUMINURIA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE BASED ON ITS SEVERITY

Abstract

Background: Chronic Obstructive Pulmonary Disease (COPD) is a major global health concern, projected to become the third leading cause of death by 2030. COPD is characterized by systemic inflammation, contributing to increased cardiovascular morbidity and mortality. Microalbuminuria (MAB), a marker of endothelial dysfunction, has been linked to heightened cardiovascular risk in COPD patients. This study explores the correlation between microalbuminuria and COPD severity using the Global Initiative for Chronic Obstructive Lung Disease (GOLD) staging.